腹腔熱灌注化療治療進展期結直腸癌臨床療效及安全性的Meta分析_《中國普外基礎與臨床雜志》

作者：

巴明臣 ¹ , 崔書中 ¹ , 駱福添 ² , 歐陽文偉 ² , 唐云強 ¹ , 吳印兵 ¹

1.廣州醫學院附屬腫瘤醫院腹外二科（廣州510095）;;
2.中山大學公共衛生學院統計學教研室（廣州510080）;

關鍵詞：

進展期結直腸癌腹腔熱灌注化療療效安全性 Meta分析

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的探討腹腔熱灌注化療（hyperthermic intraperitoneal perfusion chemotherapy，HIPC）治療進展期結直腸癌的臨床療效和安全性。
方法應用Meta分析的方法對國內、外已發表的8篇隨機對照研究的文獻進行定量綜合，以結直腸癌根治術后行HIPC治療的患者為治療組，以僅施行結直腸癌根治術的患者為對照組，比較2組患者5年生存率和3年生存率的結局變量的相對危險度（RR）及安全性。
結果入選的8篇文獻共1 501例患者，其中治療組765例，對照組736例，5年生存率的RR為2.39（95% CI: 1.66～3.45）； 3年生存率的RR為2.13(95% CI: 1.45～3.13)，提示HIPC可提高結直腸癌患者5年和3年生存率，敏感性分析證實該結論較為可靠。入選的5篇文獻對HIPC的安全性進行了描述，結果表明HIPC的潛在安全問題較小。
結論進展期結直腸癌根治術后行HIPC可以提高生存率，改善患者的預后；是否會增加患者術后并發癥發生率目前缺乏相關性研究，尚無明確的結論。

引用本文： 巴明臣,崔書中,駱福添,歐陽文偉,唐云強,吳印兵. 腹腔熱灌注化療治療進展期結直腸癌臨床療效及安全性的Meta分析. 中國普外基礎與臨床雜志, 2010, 17(7): 725-730. doi: 復制

1.	Verwaal VJ, Bruin S, Boot H, et al. 8year followup of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer [J]. Ann Surg Oncol， 2008； 15(9): 24262432.
2.	Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer [J]. J Clin Oncol， 2003； 21(20): 37373743.
3.	Elias D, Benizri E, Di Pietrantonio D, et al. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis[J]. Ann Surg Oncol， 2007； 14(2): 509514.
4.	吳承堂, 黃祥成, 卿三華. 直腸癌術式和熱灌注化療與預后的關系 [J]. 中華胃腸外科雜志, 2001； 4(2)： 8890.
5.	Verwaal VJ, van Ruth S, Witkamp A, et al. Longterm survival of peritoneal carcinomatosis of colorectal origin [J]. Ann Surg Oncol, 2005； 12(1): 6571.
6.	王付龍, 侯愛軍, 彭正. 結直腸癌切除術中腹腔低滲熱灌注化療的臨床研究 [J]. 華北國防醫藥, 2006； 18(2): 100102.
7.	Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin [J]. J Clin Oncol, 2009； 27(5): 681685.
8.	Kianmanesh R, Scaringi S, Sabate JM, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases [J]. Ann Surg, 2007； 245(4): 597603.
9.	Yan TD. Peritoneal carcinomatosis of colorectal origin: standard of care [J]. Ann Surg, 2006； 224(4): 632633.
10.	Glockzin G, Ghali N, Lang SA, et al. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer [J]. J Surg Oncol, 2009； 100(4): 306310.
11.	Brouquet A, Goéré D, Lefèvre JH, et al. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and longterm outcome [J]. Ann Surg Oncol, 2009； 16(10): 27442751.
12.	Hagendoorn J, van Lammeren G, Boerma D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival[J]. Eur J Surg Oncol, 2009； 35(8)：833837.
13.	Huh JW, Kim YJ, Kim HR. Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis[J]. World J Gastroenterol, 2009; 15(6): 756757.
14.	劉義冰, 劉巍, 洪雷, 等. 腹腔熱灌注化療毒副作用的觀察及分析 [J]. 中國普外基礎與臨床雜志, 2010； 17(3): 237239.
15.	何建苗, 蒲永東, 曹志宇, 等. 胃癌患者腹腔游離癌細胞的監測與腹腔灌注化療 [J]. 中國普外基礎與臨床雜志, 2002； 9(3): 156158.
16.	Franko J, Gusani NJ, Holtzman MP, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer [J]. Ann Surg Oncol, 2008； 15(11): 30653072.
17.	Zanon C, Bortolini M, Chiappino I, et al. Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer [J]. World J Surg, 2006； 30(11): 20252032.
18.	毛忠琦, 陸耀良, 徐乃元. 腹腔化療對大鼠結腸吻合口愈合的影響 [J]. 中國普外基礎與臨床雜志, 2002； 9(5): 335337.
19.	Cao C, Yan TD, Black D, et al. A systematic review and metaanalysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin [J]. Ann Surg Oncol, 2009； 16(8): 21522165.

1. Verwaal VJ, Bruin S, Boot H, et al. 8year followup of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer [J]. Ann Surg Oncol， 2008； 15(9): 24262432.
2. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer [J]. J Clin Oncol， 2003； 21(20): 37373743.
3. Elias D, Benizri E, Di Pietrantonio D, et al. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis[J]. Ann Surg Oncol， 2007； 14(2): 509514.
4. 吳承堂, 黃祥成, 卿三華. 直腸癌術式和熱灌注化療與預后的關系 [J]. 中華胃腸外科雜志, 2001； 4(2)： 8890.
5. Verwaal VJ, van Ruth S, Witkamp A, et al. Longterm survival of peritoneal carcinomatosis of colorectal origin [J]. Ann Surg Oncol, 2005； 12(1): 6571.
6. 王付龍, 侯愛軍, 彭正. 結直腸癌切除術中腹腔低滲熱灌注化療的臨床研究 [J]. 華北國防醫藥, 2006； 18(2): 100102.
7. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin [J]. J Clin Oncol, 2009； 27(5): 681685.
8. Kianmanesh R, Scaringi S, Sabate JM, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases [J]. Ann Surg, 2007； 245(4): 597603.
9. Yan TD. Peritoneal carcinomatosis of colorectal origin: standard of care [J]. Ann Surg, 2006； 224(4): 632633.
10. Glockzin G, Ghali N, Lang SA, et al. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer [J]. J Surg Oncol, 2009； 100(4): 306310.
11. Brouquet A, Goéré D, Lefèvre JH, et al. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and longterm outcome [J]. Ann Surg Oncol, 2009； 16(10): 27442751.
12. Hagendoorn J, van Lammeren G, Boerma D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival[J]. Eur J Surg Oncol, 2009； 35(8)：833837.
13. Huh JW, Kim YJ, Kim HR. Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis[J]. World J Gastroenterol, 2009; 15(6): 756757.
14. 劉義冰, 劉巍, 洪雷, 等. 腹腔熱灌注化療毒副作用的觀察及分析 [J]. 中國普外基礎與臨床雜志, 2010； 17(3): 237239.
15. 何建苗, 蒲永東, 曹志宇, 等. 胃癌患者腹腔游離癌細胞的監測與腹腔灌注化療 [J]. 中國普外基礎與臨床雜志, 2002； 9(3): 156158.
16. Franko J, Gusani NJ, Holtzman MP, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer [J]. Ann Surg Oncol, 2008； 15(11): 30653072.
17. Zanon C, Bortolini M, Chiappino I, et al. Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer [J]. World J Surg, 2006； 30(11): 20252032.
18. 毛忠琦, 陸耀良, 徐乃元. 腹腔化療對大鼠結腸吻合口愈合的影響 [J]. 中國普外基礎與臨床雜志, 2002； 9(5): 335337.
19. Cao C, Yan TD, Black D, et al. A systematic review and metaanalysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin [J]. Ann Surg Oncol, 2009； 16(8): 21522165.

《中國普外基礎與臨床雜志》

腹腔熱灌注化療治療進展期結直腸癌臨床療效及安全性的Meta分析

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

腹腔熱灌注化療治療進展期結直腸癌臨床療效及安全性的Meta分析

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料